Lattice_grid_med
Powered by LatticeGrid

Search Enter term and hit return. Use '*' for as a wildcard.

Publication Listing for the MeSH term dose. Found 15 abstracts

Avkshtol V, Handorf EA, Ridge JA, Leachman BK, Liu JC, Bauman J, Galloway TJ. Examining adjuvant radiation dose in head and neck squamous cell carcinoma. Head & neck. 2019 Jul;41(7):2133-42.
Dumont AG, Rink L, Godwin AK, Miettinen M, Joensuu H, Strosberg JR, Gronchi A, Corless CL, Goldstein D, Rubin BP, Maki RG, Lazar AJ, Lev D, Trent JC, von Mehren M. A nonrandom association of gastrointestinal stromal tumor (GIST) and desmoid tumor (deep fibromatosis): case series of 28 patients. Annals of Oncology. 2012 May;23(5):1335-40.   PMCID: PMC3493136 [Available on 2013/5/1]
Xu QY, He ZJ, Fan JJ, Hamilton RJ, Chen Y, Ma CM, Xing L. Registration of on-board X-ray images with 4DCT: A proposed method of phase and setup verification for gated radiotherapy. Physica Medica. 2010 Jul;26(3):117-25.   PMCID: Not required
Kuban DA, Tucker SL, Dong L, Starkschall G, Huang EE, Cheung MR, Lee AK, Pollack A. Long-term results of the M. D. Anderson randomized dose-escalation trial for prostate cancer. International Journal of Radiation Oncology Biology Physics. 2008 Jan;70(1):67-74.
Zelefsky MJ, Kuban DA, Levy LB, Potters L, Beyer DC, Blasko JC, Moran BJ, Ciezki JP, Zietman AL, Pisansky TM, Elshaikh M, Horwitz EM. Multi-institutional analysis of long-term outcome for stages T1-T2 prostate cancer treated with permanent seed implantation. International Journal of Radiation Oncology Biology Physics. 2007 Feb;67(2):327-33.
Pollack A, Zagars GK, Starkschall G, Antolak JA, Lee JJ, Huang E, von Eschenbach AC, Kuban DA, Rosen I. Prostate cancer radiation dose response: Results of the M. D. Anderson phase III randomized trial. International Journal of Radiation Oncology Biology Physics. 2002 Aug;53(5):1097-105.
Fiveash JB, Hanks G, Roach M, Wang SB, Vigneault E, McLaughlin PW, Sandler HM. 3D conformal radiation therapy (3DCRT) for high grade prostate cancer: A multi-institutional review. International Journal of Radiation Oncology Biology Physics. 2000 May;47(2):335-42.
McGuire WP, Brady MF, Ozols RF. The Gynecologic Oncology Group experience in ovarian cancer. Annals of Oncology. 1999 Jan;10:29-34.
Das IJ. Forward dose perturbation at high atomic number interfaces in kilovoltage x-ray beams. Medical Physics. 1997 Nov;24(11):1781-7.
Das IJ, Cheng CW, Fein DA, Fowble B. Patterns of dose variability in radiation prescription of breast cancer. Radiotherapy and Oncology. 1997 Jul;44(1):83-9.
Ozols RF. Controversies in the management of ovarian cancer. International Journal of Gynecological Cancer. 1997 May;7:27-32.
Adams GP, McCartney JE, Wolf EJ, Eisenberg J, Tai MS, Huston JS, Stafford WF, Bookman MA, Houston LL, Weiner LM. Optimization of in-Vivo Tumor Targeting in Scid Mice with Divalent Forms of 741f8 Anti-C-Erbb-2 Single-Chain Fv - Effects of Dose-Escalation and Repeated Iv Administration. Cancer Immunology Immunotherapy. 1995 May;40(5):299-306.
Adams GP, McCartney JE, Wolf EJ, Oppermann H, Tai MS, Eisenberg J, Giantonio B, Schultz J, Bookman MA, Laminet AA, Apell G, Stafford WF, Liu S, Huston JS, Houston LL, Weiner LM. Preclinical Studies and Optimization of Specific Tumor Delivery for 741f8 Sfv, an Anti-C-Erbb-2 Single-Chain Species. International Journal of Pharmacognosy. 1995 Jan;33:75-91.
Coia LR. The Role of Radiation-Therapy in the Treatment of Brain Metastases. International Journal of Radiation Oncology Biology Physics. 1992 Jan;23(1):229-38.
Coia LR, Aaronson N, Linggood R, Loeffler J, Priestman TJ. A Report of the Consensus Workshop Panel on the Treatment of Brain Metastases. International Journal of Radiation Oncology Biology Physics. 1992 Jan;23(1):223-7.
The above publications are sorted by year, faculty last name, and first author. Click on any highlighted author listed to find all publications attributed to that individual. Click on the publication title to see the abstract. First authors who are faculty are highlighted like this. Last authors who are faculty are highlighted like this. Other authors who are faculty are highlighted like this.

MeSH cloud from publications including the MeSH term dose

dose radiotherapy irradiation therapy carcinoma adenocarcinoma prostate-specific antigen 1st 2 radiation escalation stereotaxic fusion protein dosimetry c-erbb-2 randomized trial radical prostatectomy brain metastases central nervous-system prognosis cerebral metastases prostate cancer linear-accelerator isocentric technique patients b-cell lymphoma CONFORMAL RADIOTHERAPY phase-i trial recurrent PATIENT SELECTION fiducial markers three-dimensional conformal therapy chemotherapy prostate neoplasms new drugs external beam irradiation phase-ii-trial dose specification prostate specific antigen radiation- 78 GY specificity conservative surgery enhancement tamoxifen synchronous occurrence 4-dimensional computed-tomography progression altered RTOG Setup verification interstitial-cells BIOPSY platinum-resistant monoclonal-antibody co17-1a portal images respiratory motion I-125 immunotargeting paclitaxel-cisplatin phase-ii FAILURE BRACHYTHERAPY RADIATION-THERAPY intensity MEN 1989 sner mc-archives of surgery-v124-p191 tumor targeting less-than-or-equal-to-10 stage-iii patient setup human carcinoma immunoglobulin forms prescription points EORTC fractionation regimen in cranial irradiation paclitaxel lead pelvic irradiation imatinib mesylate familial adenomatous polyposis optimized delivery therapy-oncology-group hot spot brachytherapy idiotype antibodies postoperative taxanes calculations dose-escalation external-beam radiotherapy gynecologic-oncology-group (sfv')(2) colorectal-cancer ERA time tumor-tracking chimeric antibodies breast single-chain fv nude-mice lung-cancer cytoreductive surgery treatment external beam radiosurgery interface dosimetry attenuation randomized cyclophosphamide ct sfv escherichia-coli complications of cranial irradiation carboplatin oncology-group conformal radiotherapy platinum Registration 4DCT isotope palliative radiation therapy whole abdomen irradiation beta-catenin gene goserelin new standard head and neck cancer photon-activation therapy radiation-therapy IRRADIATION monoclonal-antibody conserving cisplatin-cyclophosphamide distributions neoplasms support TOXICITY c-kit imaging single-chain fv molecules radiolabeling adjuvant high Z leucovorin intraperitoneal chemotherapy deep fibromatosis beta-catenin-desmoid tumor-GIST-imatinib-KIT management palliation forward scatter photons kilovoltage perturbation
Last updated on Friday, July 10, 2020